critical for the maintenance of immune homeostasis in the gastrointestinal tract. Here, we show that group 3 ILC (ILC3) constitutive function is not constant across the day but instead oscilliates between active and resting phases. Coordinate responsiveness of ILC3 in the intestine depended on foodinduced expression of the neuronal hormone vasoactive intestinal peptide (VIP). Intestinal ILC3 expressed high levels of the G protein-coupled receptor, VIPR2, and activation via enteric neuronal VIP markedly enhanced IL-22 production and conferred gut protection. Conversely, deficiency of VIPR2 signalling led to impaired production of IL-22 by ILC3 and increased susceptibility to inflammatory gut disease. As such, intrinsic cellular rhythms synergise with the cyclic patterns of food intake to drive IL-22 thereby syncronizing intestinal epithelial protection via the ILC3 VIP-VIPR2 pathway.
Introduction
The gut is the largest immune organ in the body. It harbors trillions of symbiont, commensal and pathogenic bacteria 1, 2 that have important positive or deleterious effects on immune function, nutrient processing, and other host activities. Daily protection against the vast array of microorganisms that traverse the intestine depends on the enforced exclusion of potentially pathogenic microbes and harmful antigens derived from ingested material that could penetrate the epithelium via physical and immune mediated mechanisms. Rhythmic cycles within cells provide a fundamental mechanism for the body to deal with the significant fluctuations that occur in the intestine 3 . Nevertheless, protection of the intestine provides a significant challenge due to the extreme diurnal changes that occur. This necessitates coordination of physiological processes to regulate crosstalk between the microbiota and immune cells, a process essential for immune protection of the gut.
Innate lymphoid cells (ILC), particularly group 3 ILC, the most abundant ILC in the gut, are critical to neutralize invasive pathogens at the intestinal epithelial surface to ensure maintenance of homeostasis 4, 5 . ILC3-derived cytokines such as interleukin(IL)-17, IL-22 and granulocyte-macrophag colony-stimulating factor maintain immune homeostasis by triggering immune-epithelial signalling or by modulating other immune cells (e.g. monocytes) to drive tissue repair programs 4, 6, 7 . IL-22 acts mainly on non-lymphoid cells such as epithelial cells and it is essential for barrier function and tissue repair [8] [9] [10] . ILC3 are a major source of IL-22 required to protect against the inflammatory damage induced using the acute colonic model of dextran sulfate sodium (DSS) 11 , and bacterial infections such as Clostridium difficile 12 and Citrobacter rodentium 5, [13] [14] [15] [16] . This has led to intense efforts to understand the factors that modulate IL-22 expression for therapeutic approaches towards inflammatory intestinal diseases 17, 18 . In contrast to the positive repair functions mediated by IL-22, continuous exacerbated or uncontrolled activation of the IL-22 pathway, particularly in ILC3, leads to increased intestinal permeability 19 , chronic inflammation, an increased risk of inflammatory bowel disease 20, 21 , Crohn's disease 22 and colitis-associated cancer 23 . These sequelae highlight the critical requirement to tightly regulate IL-22 signalling in the mucosal epithelium.
However, the mechanims that normally restrain overproduction of IL-22 in the face of continual antigenic exposure have not yet been elucidated.
Recent transcriptomic analyses have revealed that ILCs express a large array of receptors involved in the recognition of neuropeptides, hormones and metabolic signals 24, 25 . These receptors arm immune cells with the potential to act as a rheostat, integrating diverse extrinsic and intrinsic signals to finely tune immune responses 25 . For example, hormone receptors such as the androgen receptor expressed by ILC2 protect against the development of experimental asthma in male mice 26 , while the glucocorticoid receptor found on NK cells and ILC1 is triggered by lipopolysaccharide to downregulate interferon-g production thus confering protection against septic shock 27 . A variety of other receptors including the neuroreceptors VIPR1 and VIPR2 28 , NMUR1 [29] [30] [31] and RET 11, 32 are also expressed by ILC2 and ILC3. These receptors have been shown to be important in a tissue-specific manner in the lung and the gut highlighting the novel mechanisms utilized by ILC in integrating host responses in a complex environment. These mechanisms are especially important for ILCs as they drive their rapid secretion of effector cytokines in response to stimulation, a function central to the mobilization of early immune responses 33 . In addition, ILCs constitutively secrete mediators that are important for the homeostasis of mucosal tissues 34 but how each of these types of receptors are regulated is not yet clear. Nevertheless, it is clear that disruption of ILCs through these pathways leads to altered immune responses with extremely harmful consequences for the organism 4 .
In the current study, we examined how innate immune cells which are strategically positioned at the intestinal interface integrate local neuronal-derived cues. We show that daily patterns of food intake coordinately regulated ILC3 responsivness. This cyclicity was only partially controlled by factors, such as circadian genes, that can intrinsically program cyclic rhythms within cells. Instead, ILC3 expression of the neuropeptide receptor vasoactive intestinal peptide receptor-2 (VIPR2) directly connected food intake with the intestinal neuronal expression of VIP to activate the protective IL-22 cytokine cascade. Collectively, we identify the mechanism governing ILC3 temporal regulation that ensures their optimal functional capacity by synergistic coordination with food intake to enforce innate defence and confer physiological protection of the gut.
Results

ILCs in intestinal epithelium exhibit rhythmic oscillations
Epithelial cells exhibit transcriptionally regulated diurnal fluctuations that allow temporal regulation of epithelial integrity 35, 36 . It is less clear whether ILCs, which are highly enriched in the intestinal mucosa, also exhibit cyclic patterns that connect epithelial function to immune responsiveness. To investigate whether ILCs in the gastrointestinal tract are regulated in a cyclic manner, we examined each of the ILC subsets at different stages of the light and dark cycles. All mice were fed ad libitum and housed under strict 24 hour dark-light conditions with lights being kept on for 12 h and time of light onset was denoted T = 0 (T0). At 4 h after the onset (T4) or offset (T16) of light, the function of the ILCs and other lymphocytes in tissues was determined ( Fig. 1 and Supplementary Figs. 1-3 ). We first analysed the capacity of innate lymphocytes isolated at the T4 and T16 timepoints from the small intestine ( Fig. 1a) , the lungs and the mesenteric lymph node (LN) ( Supplementary Fig. 1 ) to produce cytokines after stimulating the cells with PMA and ionomycin for 4.5 hours. NK cells and ILC1 did not exhibit a change in their production of interferon (IFN)-g or tumour necrosis factor (TNF)-a among the organs tested ( Fig. 1a ). Distinct from this, ILC2 and ILC3 showed a difference in their capacity to produce cytokines during the day and night. IL-5-producing ILC2s were signficantly increased at T16 in both small intestine and lungs ( Fig. 1a , Supplementary Fig.   1a ). ILC3 showed enhanced IL-22 production specifically in the intestine but not in the mesenteric LN draining the gut, or the lungs ( Fig. 1a , Supplementary Fig. 1 ) while IL-17 production was not markedly affected in these cells. In constrast, adaptive CD4 + T cells did not exhibit changes in proinflammatory cytokines such as IFN-g, TNF-a or IL-22 while IL-17 expression showed rhymicity as has been previously observed 37 ( Supplementary Fig. 2a,b ).
These data suggest that among lymphocytes, ILC2 and ILC3 functions are particularly sensitive to temporal regulation.
To better understand the nature of the variation in IL-5 and IL-22 production, we analysed the constitutive cytokine expression of the ILC2 and ILC3 at four different time points during the day ( Fig. 1b ). We found that production of IL-5 and IL-22 by ILC2 and ILC3, respectively, followed a diurnal pattern that peaked between T14 and T16. This indicates that the individual effector programs in ILC2 and ILC3 are regulated in a time-and tissue-specific manner. As IL-5 secretion by ILC2 has previously been reported to vary during the day 28 , we focused our analysis on IL-22 secretion by ILC3. In order to elucidate the mechanisms that might characterise the selective rhythmic expression of cytokines in intestinal ILCs, we performed RNA-seq analyses on flow cytometrically-purified ILC2 and ILC3 at T4, 10, 16 and 23 over a 24 h period from the small intestine ( Fig. 1c ). We combined both data sets to elucidate the core set of genes that oscilliated in ILC2 and ILC3. Rhythmic changes in gene expression across the four timepoints were identified using a single harmonic sinusoidal model to fit log2 transformed data to characterise the expression of a periodic pattern amongst ILC transcripts (FDR adjusted p-value < 0.05). Amongst ILC2 and ILC3 this showed enrichment of genes involved in regulation of the circadian rhythm (e.g. Dpb, Per1,2 and 3, Nr1d1, Nr1d2, Cry1 ) indicating that ILC2 and ILC3 possess functional circadian molecular machinery. Three of the the top 15 pathways identified using Reactome analyses (https://reactome.org/) were related to circadian rhythm ( Fig. 1d ). Interestingly, genes involved in intestinal tissue integrity such as the claudin family (Cldn2, Cldn15 and Cldn7) and antimicrobial proteins Reg3b also exhibited oscillation and were upregulated during the night time ( Fig. 1c ). Reactome analysis revealed that TGF-b signalling and SMAD transcriptional activity (Socs1, Ncor2, Trim33) were upregulated during the day. This increase in TGF-b signalling during the day could indicate an increase of the anti-infllammatory properties of the ILCs during the resting phase of the rodent. Finally, genes involved in metabolism, in particular enzymes involed in the cholesterol biosynthesis (Msmo1, Mvk, Nsdhl, Idi1, Fdps Dhcr24, Sqle) were also increased in the active phase. Collectively, this analysis revealed that ILCs exhibit significant cyclicity in gene regulation especially amongst genes that are central to mucosal immune protection. It also revealed unexpectedly that distinct functions of ILCs are regulated across the day in a timedependent manner to favour their pro or anti-inflammatory properties.
Intrinsic clock genes only partially regulate rhythmic ILC cytokine responses
To understand how this rhythmicity in ILC function is regulated we examined the contribution of the circadian clock gene Bmal1 (also known as Arntl or Aryl hydrocarbon receptor nuclear translocator-like protein-1) that plays a key role in intrinsically regulating cellular oscillations, particularly in cytokine production. BMAL1 rhythmically binds to DNA to activate the expression of the core clock genes Period (PER), Cryptochrome (CRY1), REV-ERBa and ROR 3 . We crossed the Il7rCre ´ Bmal1 flox/flox conditional mice to generate the Bmal1 DIL7R strain in which Bmal1 was deleted in all lymphoid lineages (data not shown). Mixed bone marrow chimeric mice were generated by transplanting a 1:1 mixture of wild-type (CD45.1 + CD45.2 + , F1) and BMAL1-lymphoid deficient bone marrow (CD45.2 +/+ Bmal1 DIL7R ) into lethally irradiated CD45.1 +/+ wild-type recipients ( Fig. 2a ). This allowed us to simultaneously examine the responsiveness of Bmal1-sufficient and replete ILC subsets derived from different donors but that were exposed to identical cellular environments during tissue reconstitution. ILC subset reconstitution, cytokine production and expression patterns were examined in mice after 8 weeks ( Fig. 2a-c ). Both wild-type and Bmal1 DIL7R bone marrow were able to reconstitute adaptive ( Fig. 2a ) and most innate lymphoid subsets in the small intestine. Notably, the frequency of Rorgt + ILC3 were significantly diminished in the Bmal1 DIL7R compartment ( Fig. 2a,b ). A significant reduction was also observed in the ability of Bmal1 DIL7R ILC3 to constitutively produce IL-22, or in response to IL-7 and IL-23, compared with wild-type ILC3 (Fig. 2c ). To test whether this defect was intrinsic to the ILC3, we purified ILC3 from wild-type and the Bmal1 DIL7R mice ( Supplementary Fig. 4 ) and analysed the production of IL-22 after 16 hours incubation with IL-7 (constitutive cytokine production), or a combination IL-7 and IL-23 to stimulate cytokine production ( Fig. 2d ). In both conditions, ILC3 purified from Bmal1 DIL7R mice produced less IL-22 compared with wild-type ILC3. Thus, BMAL1 is required for optimal secretion of IL-22, however, whether BMAL1 generally controls the cyclic expression of cytokines in ILC was not clear. To understand this, we analysed IL-5 production in ILC2 isolated from the small intestine of wild-type and Bmal1 DIL7R mice at T4 and T16 ( Fig. 2e ,f). Temporal analyses of cytokine production revealed that loss of BMAL1 did not substantially influence the overall production or the oscillatory expression pattern of IL-5 by ILC2 ( Fig. 2e , left panel). This was in contrast to Bmal1 DIL7R ILC3 where we observed a marked reduction in constitutive secretion of IL-22 and a significantly diminished amplitude of the oscillation wave although the capacity to produce cytokine was not completely abolished ( Fig. 2f , left panel). The provision of IL-7 and IL-23 in vitro increased the responsiveness of both WT and Bmal1-deficient ILC2 by ~ 1.3-fold ( Fig. 2e , right panel), while the frequency of ILC3 able to produce IL-22 was increased ~6.5-fold. Despite the fact that stimulation with IL-23 did not restore IL-22 production in Bmal1-deficient ILC3 to wild-type levels ( Fig. 2f , right panel), the oscilliation in cytokine production remained although the amplitude of cyclic production was reduced. In contrast, ILC2, however, BMAL1 was not required to establish cyclicity. Collectively, these data demonstrate that BMAL1 only partially influences ILC3 cyclicity and that other factors must be important in regulating this rhythm.
Caloric intake is synchronized with ILC functional rhythmicity
Given that genomic deletion of Bmal1 in ILC3 did not fully ablate rhythmic IL-22 cytokine production, we hypothesised that the cyclic behaviour of this subset in the gut may a depend on a combination of intrinsic and extrinsic factors. Because pathways involved in cellular metabolism were differentially regulated in our RNA-seq ( Fig. 1c ), we first mapped food intake across the light-dark phases of the 24 h period by tracking food consumption at different times ( Fig. 3a ). This revealed that the rate of food intake by mice was rhythmic and the pattern was similar to that observed for cytokine expression ( Fig. 1b ). Maximal food intake occurred during the dark phase while little food was consumed during the light phase. To understand whether food intake influenced ILC cyclic behaviour, food was provided either only during the dark (night food, high food intake) or the light (day food, low food intake) phase for seven days to adjust to this time-restricted feeding regime and establish new cellular cycles. The response of ILC2 and ILC3 were analysed at T4 after this period (Fig. 3b ). For both intestinal ILC2 and ILC3, it was revealed that the frequency of ILC constitutively producing cytokines was increased when food was available during the dark phase ( Fig. 3c, d ). Interestingly, these differences were not observed in the lungs or the mesenteric LN, suggesting that the local regulation of ILCs in the intestine was directly dependent on food intake. We observed no differences in cytokine production in T cells (data not shown). To test whether the microbiota could be responsible for these differences, mice were treated with antibiotics for two weeks.
Mice were given food only during the night, or only during the day, together with water containing antibiotics. Control mice received ad libitum access to food and water without antibiotics ( Fig. 3e , blue bar). This quenched microbial signals and showed that antibiotic treatment during the active phase did not alter IL-22 production by ILC3 ( Fig. 3e , red hatched blue bar). Both groups of mice that could consume food during the active phase showed an increased frequency of IL-22-producing cells compared with antibiotic treated mice fed only during the day (Fig. 3d , red hatched white bar) consistent with our earlier findings. Because all mice were analysed at T4, we wondered whether completely limiting access to food for a short period during the day would be sufficient to reduce cytokine expression in ILCs. To address this question we removed food for 16 hours prior to our analyses at T4 ( Fig. 3f,g ). This revealed that under time-restricted feeding, ILC2 and ILC3 isolated from the small intestine of fasted mice both showed reduced IL-5 ( Fig. 3f ) and IL-22 expression constitutively and following stimulation with IL-23, respectively, compared with fed mice, while ILCs from the mesenteric LN showed no changes ( Fig. 3g ). This effect was also observed in small intestinal ILC3 from fed and fasted animals indicating that the capacity of these cells to constitutively produce IL-22, and in response to IL-23, was imprinted in vivo ( Fig. 3h ). Combined, these results suggest that ILC3 responsiveness is highly tissue-specific and plays an important role in coordinating signals stimulated by food intake which overlies the intrinsic foundational circadian molecular machinery.
Intestinal ILC3 differentially express the intestinal neuropeptide receptor VIPR2
To elucidate the potential mechanisms that might control the tissue-specific regulatory program observed in small intestinal ILCs, single cell RNA-seq was performed ( Fig. 4a -c) on ILCs isolated from mice at T4. Analyses of data using t-Distributed Stochastic Neighbour Embedding (t-SNE) 38 allowed us to visualize eight distinct clusters which included ILC1 and NK cells (cluster 7), ILC2 (cluster 4) and four different subsets of ILC3 (Clusters 1, 2, 3, 6) ( Fig. 4a ). This revealed that ILC3 in cluster 6 expressed the intestinal neuroendocrine receptor Vipr2 (also known as VPAC2). This cluster mainly contained ILC3 expressing Ccr6 and Cd4 but were negative for Ncr1 and Tbx21 (Fig. 4b,c ). While other ILC3 clusters constitutively expressed cytokines such as Csf2 and Il2 (cluster 1 and 2), the VIPR2 + ILC3 cluster mainly expressed Il22 together with some Il17 (Fig. 4c ). In the colon, we observed only one cluster of ILC3 that constitutively expressed Il22. These ILC3 co-expressed Ccr6, Cd4 and some cells expressed Vipr2 (cluster 4, Supplementary Fig. 5 ). VIPR2 responds to VIP, a neuropeptide that is centrally involved in controlling cellular rhythms [39] [40] [41] and is highly expressed in intestinal neurons to coordinate feeding responses 42 . More recently, VIP has been reported to drive IL-5 cytokine production in ILC2 for immune protection 28 . Thus, we hypothesised that expression of the receptor VIPR2 in ILC3 may act to coordinate the consumption of food intake with immune responsiveness of innate cells. Initially, we examined the localisation of VIP + neurons in the small intestine by confocal and light sheet imaging of whole gut sections. Neurons were identified as b3-tubulin + and co-stained with the neuronal mediator VIP that activates VIPR ( Fig. 4d,e ). This showed an extensive network of neurons (stained for b3-tubulin) extending from the the base of the intestinal crypts into the villus within the submucosa and adjacent to the lacteals. However, no VIP could be detected in the intestinal muscularis mucosae ( Fig. 4d ,e, Supplementary Movie 1). Staining of ILC3 (Rorgt + CD3e -) revealed that intestinal neurons, VIP and ILC3 are closely connected anatomically positioning them for direct interations mediated by a feeding signal network ( Fig. 4f ). To determine whether food intake is synchronized with VIP expression, we next examined small intestinal sections for co-staining for intestinal neurons and VIP (Fig. 4g ). This revealed that small intestinal tissue from fed mice showed co- provides a direct link between VIP expression and ingestion of food as indicated by a strong correlation between feeding and VIP colocalization.
Feeding coordinates ILC3 IL-22 production and intestinal protection
To investigate the importance of the food intake induced VIP expression in detail, we assessed whether VIP exposure influences ILC3 activity. We stimulated intestinal cells with IL-7 and IL-23 in presence or absence of VIP. Dibutyryl cyclic-AMP (cAMP), a cell permeable cAMP analog that bypasses VIPR2 engagement to mimic direct cAMP stimulation and activate proten kinases 43 , was included as a positive control. Cells were obtained from mice that had been fasted for 16 hours to deplete VIP stores and hence their intrinsic capacity to stimulate ILC3. After 4.5 hours stimulation, intracellular expression of IL-22 was significantly increased in ILC3 cultivated in presence of synthetic VIP, or Dibutyryl cAMP ( Fig. 5a ). To determine whether VIP acted directly on ILC3, we purified small intestinal ILC3 from mice that had not been starved. These cells were cultivated in the presence of synthetic VIP, or dibutyryl cAMP for 16 hours (Fig. 5b) . Interestingly, the addition of VIP to ILC3 cultures containing the survival factor IL-7 was sufficient to induce the secretion of IL-22, while the presence of IL-23 appeared to synergise with VIP to enhance IL-22 production (Fig. 5b ). The influence of VIP, and dibutyryl cAMP, on IL-22 expression by ILC3 was dose dependent and occurred regardless of whether the induction of IL-22 was constitutive or provoked by the addition of IL-7 and IL-23 ( Fig. 5c,d ). To establish that VIP induction of IL-22 acted through the VIPR2 receptor itself, ILC3 were stimulated with the VIPR2 agonist BAY55-9837 ( Fig. 5e ).
Strikingly, the response via VIP stimulation and in the presence of the VIPR2 agonist elicited similar IL-22 responsiveness in purified ILC3 while the VIPR2 antagonist PG99-465 largely blocked IL-22 secretion ( Fig. 5f ). Collectively, these findings connect the ingestion of food that drives VIP release in the small intestine with the coordinate enhancement of IL-22 secretion through VIPR2, a mechanism that would facilitate repair of tissue microabrasions of the intestinal epithelial that occur during feeding and exclude breach of the mucosal surface by microorganisms.
To definitively show that induction of IL-22 in ILC3 is mediated via VIP induction in vivo, mice were injected intraperitoneally with VIP, or PBS (control), 2 hours before analysis of the small intestinal ILC2 and ILC3 subsets ( Fig. 6a ). ILC3 exposed to VIP in vivo showed enhanced IL-22 production, but this treatment did not alter the induction of IL-17 secretion in these cells, or IL-5 secretion by in ILC2 (Fig. 6a ). Mice deficient for VIPR2 (Vipr2 -/-) showed a significant reduction in the proportion of ILC3 able to constitutively express IL-22 ( Fig. 6b ).
To formally prove that VIP enhanced IL-22 production in ILC3 via VIPR2 signalling we purified ILC3 from wild-type and Vipr2 -/and incubated the cells with IL-7 and IL-23 in presence or absence of VIP. After 16 hours of culture, we observed a strong upregulation of IL-22 secretion in wild-type cultures, while Vipr2 -/-ILC3 failed to respond to VIP (Fig. 6c ).
This failure to respond was not attributable to fewer ILC3 that could occur if VIPR2 was required for the development or maintenance of this subset as Vipr2 -/mice had similar numbers of intestinal ILC compared with wild-type mice ( Supplementary Fig. 6 ). Thus the VIP:VIPR2 axis is required for optimal timing of the induction of IL-22 secretion by ILC3.
To understand whether VIP contributes to the physiological protection of the intestinal epithelium, we treated wild-type and Vipr2 -/mice with low dose of dextran sodium sulfate DSS (1.5% w/v) for 5 days. While wild-type mice maintained their weight after 8 days of treatment, Vipr2 -/animals started to lose weight after 5 days ( Fig. 7a ). Vipr2 -/mice also showed more severe signs of colitis with shorter colon length ( Fig. 7b ) and reduced secretion of IL-22 by ILC3 ( Fig. 7c ). Histological analysis of the colon in Vipr2 -/mice showed intestinal ulceration ( Fig. 7d) together with significantly increased mucosal thickness ( Previous studies have shown that neuroimmune hubs composed of lymphocyte subsets, metabolic signals and neuronal coregulators play a key role in orchestrating context dependent immune protection 28, 31, [44] [45] [46] [47] . In particular, ILC2 have been shown to be responsive to VIP through expression of VIPR2 28 . This pathway coordinates eosinophil recruitment and accumulation in the lung in a manner that parallels post-prandial induction of IL-5 secretion from intestinal ILC2 after feeding. Thus, we proposed that VIP-VIPR2 signalling predominates in ILC3. We found that IL-5 production by intestinal ILC2 was not intrinsically regulated by central clock machinery. In contrast, ILC3 were coregulated by intrinsic signals from BMAL1, and extrinsic signals from feeding, which itself was cyclicly regulated. As only part of the cell rhymicity program was governed by BMAL1, genetic ablation enabled us to uncouple the intrinsic pathway from extrinsic regulation of ILC3 activation revealing that ILC3-IL-22
functionality was tied to feeding patterns which would potentially also influence cellular metabolism and signalling.
As ILCs are thought to be almost exclusively lodged within tissues and positioned at barrier surfaces with little migratory capacity or ability to exert influence beyond the resident tissue 48, 49 , this constraint would likely significantly limit their capacity to exert broader protective functions without additional mechanisms driving the responsiveness of ILC with intrinsic and environmental stimuli. How then different mucosal barriers are protected by different ILC subsets has not been clear. Recently, it has been discovered that ILC2 could be mobilized from the bone marrow and traffick to the lung in response to helminth infection, a capacity regulated by sphingosine 1-phosphate (S1P) 50 and dependent on the cyclic regulator BMAL1 51 . ILC2 are also regulated by the VIP-VIPR2 circuit to drive accumulation of key lymphocytes in the lung through the systemic release of IL-5 28 . Thus multiple, but distinct mechanisms, regulate ILC2 functionality allowing local and distant impacts on immune regulation. In contrast, we found that ILC3 responsiveness was highly tissue-specific and its IL-22 production was modulated by direct exposure to VIP from enteric neurons. Collectively, these data reveal that the gut ILC3-neuronal hub forms a very tightly regulated tissue-specific circuit executed exclusively by local cues. By deleting VIPR2 signalling, we demonstrated the critical requirement for the VIP-VIPR2 signalling pathway in eliciting ILC3-dependent IL-22 cytokine production to control inflammatory intestinal disease. This is consistent with the effector role of IL-22 in protecting against the development of inflammatory bowel disease and chronic colitis in both humans 52, 53 and mouse models 10, 54, 55 . Thus, although the cellular source of IL-22 has been known for some time, it has not been understood the exact signals that allow for upregulation, or indeed downregulation which is equally important in limiting the immunopathology associated with excess IL-22. Importantly, these data reveal a previously uncharacterised mechanism for coordinating how intestinal responses are matched to the stimulatory burden of the gut and orchestrate induction of homeostatic tissue repair pathways for mucosal protection. Furthermore, it highlights the differential contributions and mechanistic strategies utilized by ILC2 and ILC3 to finely tune local and distant ILC effector responses to orchestrate mucosal barrier protection, segregating homeostatic from proinflammatory functions of these cells. Our present findings shed new light on how VIPR2 expressed by ILC3 confer immediate tissue protection through coordinated neuroimmune sensory responses establishing their unique role in coordinating food-induced VIP secretion with IL-22-driven cytokine protection.
Methods
Mice
Bmal1 fl/fl (B6.129S4(Cg)-Arntl tm1Weit /J) 56 , Il7r Cre 57 , Vipr2 -/-(B6.129P2-Vipr2 tm1Ajh /J) 58 , Rorc(gt) +/GFP 59 and Rag2 -/gc -/-60 mice were maintained on a C57BL/6 (Ly5.2) background (all originally derived from the Jackson Laboratory) and have been described previously. 
Isolation of lymphoid cells
Single cell suspensions of lymphocytes were isolated from the small intestine and colon following incubation for 40 min at 37°C in Ca 2+ -and Mg 2+ -free Hanks media containing 2% (IL22JOP, eBioscience). Cells were analysed using a FACS Canto II or Fortessa X20 (BD Biosciences) and FlowJo software was used for analysis. Flow cytometric sorting was performed with a FACSAria III (BD Biosciences). ELISA Kit (Thermo Fisher Scientific).
ILC3 isolation and in vitro stimulation
In vivo activation with exogenous VIP
For all in vivo experiments with VIP treatment, an intraperitoneal (i.p.) administered dose of 2 nmol VIP in PBS per mouse or PBS alone was injected two hours before tissue harvest.
DSS-induced colitis.
Dextran sodium sulfate (DSS) (molecular mass 36,000 -50,000 Da; MP Biomedicals) was added into drinking water 1.5% (w/v) for five days followed by three days of regular water. Mice were analysed on day eight. Mice were monitored daily for weight loss, stool consistency and hematochezia.
RNA sequencing and analyses
ILC2 and ILC3 cells were purified by flow cytometric sorting (FACS Aria, BD Biosciences) at four different time points (T4, T10, T16, T23) from female wild-type mice. One to two biological replicates were generated for each subset from small intestine. RNA was isolated using a QIAGEN RNeasy Micro kit. Libraries were generated using the Illumina Truseq RNA sample preparation kit following the manufacturer's instructions and subjected to transcriptome 85 bp single end sequencing on an Illumina Next-Seq instrument. Reads were aligned to the GRCm38/mm10 build of the Mus musculus genome using the Rsubread aligner 62, 63 . Uniquely mapped reads were retained and genewise counts were obtained using featureCounts 64 and NCBI RefSeq annotation. Differential expression analyses were then undertaken using the edgeR 65 and limma 66 software packages. Lowly expressed genes were filtering using edgeR's filterByExpr function with default settings. Additionally genes without current annotation, ribosomal RNAs, non-protein coding immunoglobulins, predicted/unknown/pseudo genes, and those not on known chromosomes were also removed.
Compositional differences between libraries were normalised using the trimmed mean of log expression ratios (TMM) method 67 . To remove unwanted variation from the data and adjust for differences between the ILC2 and ILC3 samples, the RUVIII alogorithm from the ruv software package 68 was applied with k=4 to the log2 counts per million (CPM) transformed data. A single harmonic sinusoidal model was then fit to the corrected data and cyclic genes were identified using robust empirical bayes moderated t-statistics with a trended prior variance 69 . P-values were adjusted using the Benjamini and Hochberg method to control the FDR below 5%. Analysis of the Reactome database was carried out using limma's kegga function. The heatmap was generated using the CRAN package pheatmap version 1.0.12.
Single cell RNA sequencing and analysis
For single cell RNA sequencing (scRNA-seq), ILC were sorted as lin -(CD3e -TCRb -CD19 -B220 -Gr1 -CD11b -) CD45 + IL-7R + CD90 + cells into ice cold 0.5% BSA in PBS and processed through the Chromium Single Cell 3′ v2 Library Kit (10´ Genomics) according to the manufacturer's protocol. Each channel was loaded with 20,000 cells from each tissue, yielding 5439-7388 single cells for analysis from small intestine and colon. The cells were then partitioned into gel beads in emulsion in the instrument, where cell lysis and barcoded reverse transcription of RNA occurred, followed by amplification, shearing, and 5′-adaptor and sample index attachment. Libraries were sequenced on an Illumina NextSeq platform. Reads from each sample were separately processed using 10´ Genomics' Cell Ranger software (v3.0.2).
Cellranger mkfastq was used to demultiplex the Illumina sequencer's base for each flowcell directory into FASTQ files. Next, 'cellranger count' was used to generate single cell gene count matrices against 10´ Genomics' pre-built mm10 reference genome and transcriptome (v3.0.0).
All subsequent analysis was performed in R (v3.6.0) 70 and Bioconductor (v3.9) 71 and simpleSingleCell workflow 72 . The DropletUtils package (v1.4.0) was used to create a SingleCellExperiment for each sample from the Cell Ranger output directories and to identify empty droplets 73 . Quality control on the cells was performed using the scater package (v1.12.2) 74 with two rounds of outlier detection and removal. Cells were declared as outliers and removed if they satisfied any of the following criteria: Read counts more than three median absolute deviations (MADs) below the median (log10 scale); Number of genes detected more than three MADs below the median (log10 scale); Percentage of reads coming from the mitochondria more than three MADs above the median. Detection of doublet libraries was performed using a 2-stage strategy similar to that of Pijuan-Sala et al. 75 . In total, this identified 262 putative doublets (211 from the Fed Colon and 51 from the Fed SI) which were removed from subsequent analysis. We then performed principal component analysis (PCA) across all samples and used the mutual nearest neighbours corrected values, we applied t-stochastic neighbourhood embedding (t-SNE) using the Rtsne package (v0.13)(https://cran.rproject.org/web/packages/Rtsne). To identify cluster-specific marker genes, we performed Welch t-tests on the log-expression values for every gene and between every pair of clusters.
Histology and confocal imaging
For histological analyses, tissues were fixed in 10% neutral buffered formalin and processed for wax embedding and routine hematoxylin and eosin (H&E) staining. Tissues were analyzed with an Aperio ImageScope v11.2.0.780 software and features were blindly scored for the presence of mucosal ulceration, mucosal height, epithelial irregularity and lymphocyte infiltration using the grading system: 0=no changes, 1=mild changes, 2= moderate changes and 3=severe changes.
For confocal imaging analysis, intestinal tissues were gently flushed with PBS then cut longitudinally and formed into a 'Swiss roll' for visualization of the full length of the tissue.
After fixation of 4% paraformaldehyde for two hours, the Swiss rolls were dehydrated overnight in 30% sucrose prior to embedding in OCT, frozen and stored in 80°C. Frozen tissues were sliced using a cryostat to 20 µm thick sections and fixed in cold acetone for 10 min.
Tissues were washed with PBS and blocked with PBS containing 3% BSA, 0.03% Triton X-100 for two hours at room temperature. Tissue sections were then rinsed in staining buffer (1% BSA, 0.03% Triton X-100 in PBS) and incubated with anti-b-tubulin III Alexa 594 (TUBB3, Biolegend), anti-VIP Alexa 647 (H-6, Santa-Cruz) and anti-CD3e Pacific blue (OKT3, eBioscience), Hoechst 33342 (Thermofisher) and SYTO Ò 24 (Invitrogen). Tissues were stained overnight at 4°C with antibodies diluted in PBS containing 1% BSA, 0.03% Triton X-100 (Sigma). Tissue sections were then washed three times then mounted with ProLong Gold mounting medium (Invitrogen). Images were acquired on a Zeiss LSM880 NLO confocal microscope.
For whole mount staining, small intestinal tissues were cleaned and cut in small sections (~ 0.5 cm). Sections were fixed in 4% PFA for two hours at room temperature. Afterwards the tissue was washed in PBS and blocked with PBS containing 3 % BSA and 0.3% Triton X-100 for 12 hours. The tissue was stained for 48 hours at 4 °C with the following antibodies: anti-b-tubulin III Alexa 594, anti-VIP Alexa 647 and anti-CD3e Pacific blue or Hoechst 33342. Subsequently gut samples were cleared using Ce3D reagent 76 . The tissue was then embedded in low-melting temperature agarose (Bio-Rad) in a 1 mL syringe to be imaged with a Zeiss Z.1 light sheet (Zeiss) microscope or mounted on a microscope slide and captured under a Zeiss LSM 880 NLO confocal microscope equipped with Zen software (Zeiss). Surface reconstruction was performed by using Imaris software (Version 9.3) (Bitplane). Data analyses was via a custom macro in FIJI 77 .
Oral antibiotic treatment
Mice were given unrestricted access to drinking water containing a mix of ampicillin (1 mg/mL), streptomycin (5 mg/mL) and colistin (1 mg/mL) (Sigma) for two weeks [78] [79] [80] . Gut decontamination was evaluated by macroscopic evaluation of caecal hypertrophy. 
Statistical analysis
Data availability
Single cell RNAseq profiling data that support the findings of this study have been deposited in the Gene Expression Omnibus (GEO) repository with the accession code GSEXXX. 
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